Secreted phospholipase A₂ is increased in meconium-stained amniotic fluid of term gestations: potential implications for the genesis of meconium aspiration syndrome

References

• Woods JR, Glantz JC. Significance of amniotic fluid meconium. In: Creasy RK, Resnik R, eds. Maternal fetal medicine principles and practices. 3rd ed. Philadelphia: W.B. Saunders Company; 1994:413–22
   Google Scholar
• Ross MG. Meconium aspiration syndrome – more than intrapartum meconium. N Engl J Med 2005;353:946–8
   PubMed Web of Science ®Google Scholar
• Ahanya SN, Lakshmanan J, Morgan BL, et al. Meconium passage in utero: mechanisms, consequences, and management. Obstet Gynecol Surv 2005;60:45–56; quiz 73–44
   PubMed Web of Science ®Google Scholar
• Lakshmanan J, Ross MG. Mechanism(s) of in utero meconium passage. J Perinatol 2008;28:S8–13
   PubMed Web of Science ®Google Scholar
• Caughey AB, Musci TJ. Complications of term pregnancies beyond 37 weeks of gestation. Obstet Gynecol 2004;103:57–62
   PubMed Web of Science ®Google Scholar
• Bhat R, Vidyasagar D. Delivery room management of meconium-stained infant. Clin Perinatol 2012;39:817–31
   PubMed Web of Science ®Google Scholar
• Kariniemi V, Harrela M. Significance of meconium staining of the amniotic fluid. J Perinat Med 1990;18:345–9
   PubMed Web of Science ®Google Scholar
• Maymon E, Chaim W, Furman B, et al. Meconium stained amniotic fluid in very low risk pregnancies at term gestation. Eur J Obstet Gynecol Reprod Biol 1998;80:169–73
   PubMed Web of Science ®Google Scholar
• Abramovici H, Brandes JM, Fuchs K, et al. Meconium during delivery: a sign of compensated fetal distress. Am J Obstet Gynecol 1974;118:251–5
   PubMed Web of Science ®Google Scholar
• Fujikura T, Klionsky B. The significance of meconium staining. Am J Obstet Gynecol 1975;121:45–50
   PubMed Web of Science ®Google Scholar
• Lee KA, Mi Lee S, Jin Yang H, et al. The frequency of meconium-stained amniotic fluid increases as a function of the duration of labor. J Matern Fetal Neonatal Med 2011;24:880–5
   PubMed Web of Science ®Google Scholar
• Sheiner E, Hadar A, Shoham-Vardi I, et al. The effect of meconium on perinatal outcome: a prospective analysis. J Matern Fetal Neonatal Med 2002;11:54–9
   PubMedGoogle Scholar
• Oyelese Y, Culin A, Ananth CV, et al. Meconium-stained amniotic fluid across gestation and neonatal acid-base status. Obstet Gynecol 2006;108:345–9
   PubMed Web of Science ®Google Scholar
• Romero R, Hanaoka S, Mazor M, et al. Meconium-stained amniotic fluid: a risk factor for microbial invasion of the amniotic cavity. Am J Obstet Gynecol 1991;164:859–62
   PubMed Web of Science ®Google Scholar
• Mazor M, Furman B, Wiznitzer A, et al. Maternal and perinatal outcome of patients with preterm labor and meconium-stained amniotic fluid. Obstet Gynecol 1995;86:830–3
   PubMed Web of Science ®Google Scholar
• Markovitch O, Mazor M, Shoham-Vardi I, et al. Meconium stained amniotic fluid is associated with maternal infectious morbidity in pre term delivery. Acta Obstet Gynecol Scand 1993;72:538–42
   PubMed Web of Science ®Google Scholar
• Piper JM, Newton ER, Berkus MD, et al. Meconium: a marker for peripartum infection. Obstet Gynecol 1998;91:741–5
   PubMed Web of Science ®Google Scholar
• Chapman S, Duff P. Incidence of chorioamnionitis in patients with meconium-stained amniotic fluid. Infect Dis Obstet Gynecol 1995;2:210–12
   PubMedGoogle Scholar
• Usta IM, Sibai BM, Mercer BM, et al. Use of maternal plasma level of zinc-coproporphyrin in the prediction of intrauterine passage of meconium: a pilot study. J Matern Fetal Med 2000;9:201–3
   PubMedGoogle Scholar
• Tran SH, Caughey AB, Musci TJ. Meconium-stained amniotic fluid is associated with puerperal infections. Am J Obstet Gynecol 2003;189:746–50
   PubMed Web of Science ®Google Scholar
• Josephson A. An epidemiologic study of postcesarean infection. Am J Infect Control 1984;12:19–25
   PubMed Web of Science ®Google Scholar
• Berkus MD, Langer O, Samueloff A, et al. Meconium-stained amniotic fluid: increased risk for adverse neonatal outcome. Obstet Gynecol 1994;84:115–20
   PubMed Web of Science ®Google Scholar
• Escobar GJ, Li DK, Armstrong MA, et al. Neonatal sepsis workups in infants >/=2000 grams at birth: A population-based study. Pediatrics 2000;106:256–63
   PubMed Web of Science ®Google Scholar
• Kayange N, Kamugisha E, Mwizamholya DL, et al. Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza-Tanzania. BMC Pediatr 2010;10:39
   PubMed Web of Science ®Google Scholar
• Schrag SJ, Cutland CL, Zell ER, et al. Risk factors for neonatal sepsis and perinatal death among infants enrolled in the prevention of perinatal sepsis trial, Soweto, South Africa. Pediatr Infect Dis J 2012;31:821–26
   PubMed Web of Science ®Google Scholar
• Altshuler G, Arizawa M, Molnar-Nadasdy G. Meconium-induced umbilical cord vascular necrosis and ulceration: a potential link between the placenta and poor pregnancy outcome. Obstet Gynecol 1992;79:760–6
   PubMed Web of Science ®Google Scholar
• Spinillo A, Fazzi E, Capuzzo E, et al. Meconium-stained amniotic fluid and risk for cerebral palsy in preterm infants. Obstet Gynecol 1997;90:519–23
   PubMed Web of Science ®Google Scholar
• Redline RW. Severe fetal placental vascular lesions in term infants with neurologic impairment. Am J Obstet Gynecol 2005;192:452–7
   PubMed Web of Science ®Google Scholar
• McIntyre S, Taitz D, Keogh J, et al. A systematic review of risk factors for cerebral palsy in children born at term in developed countries. Dev Med Child Neurol 2013;55:499–508
   PubMed Web of Science ®Google Scholar
• Andres RL, Saade G, Gilstrap LC, et al. Association between umbilical blood gas parameters and neonatal morbidity and death in neonates with pathologic fetal acidemia. Am J Obstet Gynecol 1999;181:867–71
   PubMed Web of Science ®Google Scholar
• Ellis M, Manandhar N, Manandhar DS, et al. Risk factors for neonatal encephalopathy in Kathmandu, Nepal, a developing country: unmatched case-control study. BMJ 2000;320:1229–36
   PubMed Web of Science ®Google Scholar
• Hayes BC, Cooley S, Donnelly J, et al. The placenta in infants >36 weeks gestation with neonatal encephalopathy: a case control study. Arch Dis Child Fetal Neonatal Ed 2013;98:F233–9
   PubMed Web of Science ®Google Scholar
• Hayes BC, McGarvey C, Mulvany S, et al. A case-control study of hypoxic-ischemic encephalopathy in newborn infants at >36 weeks gestation. Am J Obstet Gynecol 2013;209:29.e1--29.e19
   Web of Science ®Google Scholar
• Vidyasagar D, Harris V, Pildes RS. Assisted ventilation in infants with meconium aspiration syndrome. Pediatrics 1975;56:208–13
   PubMed Web of Science ®Google Scholar
• Vidyasagar D, Lukkarinen H, Kaapa P, et al. Inflammatory response and apoptosis in newborn lungs after meconium aspiration. Biotechnol Prog 2005;21:192–7
   PubMed Web of Science ®Google Scholar
• Vidyasagar D, Zagariya A. Studies of meconium-induced lung injury: inflammatory cytokine expression and apoptosis. J Perinatol 2008;28:S102–7
   PubMed Web of Science ®Google Scholar
• Katz VL, Bowes JrWA. Meconium aspiration syndrome: reflections on a murky subject. Am J Obstet Gynecol 1992;166:171–83
   PubMed Web of Science ®Google Scholar
• Cleary GM, Wiswell TE. Meconium-stained amniotic fluid and the meconium aspiration syndrome. An update. Pediatr Clin North Am 1998;45:511–29
   PubMed Web of Science ®Google Scholar
• Blackwell SC, Carreno CA, Hassan SS, et al. Meconium staining and meconium aspiration syndrome. Is there seasonal variation? Fetal Diagn Ther 2001;16:208–10
   PubMedGoogle Scholar
• Ziadeh SM, Sunna E. Obstetric and perinatal outcome of pregnancies with term labour and meconium-stained amniotic fluid. Arch Gynecol Obstet 2000;264:84–7
   PubMed Web of Science ®Google Scholar
• Blackwell SC, Moldenhauer J, Hassan SS, et al. Meconium aspiration syndrome in term neonates with normal acid-base status at delivery: is it different? Am J Obstet Gynecol 2001;184:1422–5; discussion 1425–6
   PubMed Web of Science ®Google Scholar
• Manganaro R, Mami C, Palmara A, et al. Incidence of meconium aspiration syndrome in term meconium-stained babies managed at birth with selective tracheal intubation. J Perinat Med 2001;29:465–8
   PubMed Web of Science ®Google Scholar
• Sedaghatian MR, Othman L, Hossain MM, et al. Risk of meconium-stained amniotic fluid in different ethnic groups. J Perinatol 2000;20:257–61
   PubMedGoogle Scholar
• Srinivasan HB, Vidyasagar D. Meconium aspiration syndrome: current concepts and management. Compr Ther 1999;25:82–9
   PubMedGoogle Scholar
• Dargaville PA, Copnell B. The epidemiology of meconium aspiration syndrome: incidence, risk factors, therapies, and outcome. Pediatrics 2006;117:1712–21
   PubMed Web of Science ®Google Scholar
• Vain NE, Szyld EG, Prudent LM, et al. Oropharyngeal and nasopharyngeal suctioning of meconium-stained neonates before delivery of their shoulders: multicentre, randomised controlled trial. Lancet 2004;364:597–602
   PubMed Web of Science ®Google Scholar
• Fraser WD, Hofmeyr J, Lede R, et al. Amnioinfusion for the prevention of the meconium aspiration syndrome. N Engl J Med 2005;353:909–17
   PubMed Web of Science ®Google Scholar
• Becker S, Solomayer E, Dogan C, et al. Meconium-stained amniotic fluid – perinatal outcome and obstetrical management in a low-risk suburban population. Eur J Obstet Gynecol Reprod Biol 2007;132:46–50
   PubMed Web of Science ®Google Scholar
• Fanaroff AA. Meconium aspiration syndrome: historical aspects. J Perinatol 2008;28:S3–7
   Google Scholar
• de Beaufort AJ. Early human development at the perinatal interface: meconium stained amniotic fluid (MSAF) and meconium aspiration syndrome (MAS). Early Hum Dev 2009;85:605
   PubMed Web of Science ®Google Scholar
• van Ierland Y, de Beaufort AJ. Why does meconium cause meconium aspiration syndrome? Current concepts of MAS pathophysiology. Early Hum Dev 2009;85:617–20
   PubMed Web of Science ®Google Scholar
• Martin GI, Vidyasagar D. Introduction: proceedings of the first international conference for meconium aspiration syndrome and meconium-induced lung injury. J Perinatol 2008;28:S1–2
   PubMed Web of Science ®Google Scholar
• De Luca D, Minucci A, Tripodi D, et al. Role of distinct phospholipases A2 and their modulators in meconium aspiration syndrome in human neonates. Intensive Care Med 2011;37:1158–65
   PubMed Web of Science ®Google Scholar
• Uhing MR, Bhat R, Philobos M, et al. Value of amnioinfusion in reducing meconium aspiration syndrome. Am J Perinatol 1993;10:43–5
   PubMedGoogle Scholar
• Mandelbaum B. Gestational meconium in the high-risk pregnancy. Obstet Gynecol 1973;42:87–92
   PubMed Web of Science ®Google Scholar
• Ohana O, Holcberg G, Sergienko R, et al. Risk factors for intrauterine fetal death (1988–2009). J Matern Fetal Neonatal Med 2011;24:1079–83
   PubMed Web of Science ®Google Scholar
• Brailovschi Y, Sheiner E, Wiznitzer A, et al. Risk factors for intrapartum fetal death and trends over the years. Arch Gynecol Obstet 2012;285:323–9
   PubMed Web of Science ®Google Scholar
• Tyler DC, Murphy J, Cheney FW. Mechanical and chemical damage to lung tissue caused by meconium aspiration. Pediatrics 1978;62:454–9
   PubMed Web of Science ®Google Scholar
• Kisala JM, Ayala A, Stephan RN, et al. A model of pulmonary atelectasis in rats: activation of alveolar macrophage and cytokine release. Am J Physiol 1993;264:R610–14
   Google Scholar
• Zagariya A, Bhat R, Uhal B, et al. Cell death and lung cell histology in meconium aspirated newborn rabbit lung. Eur J Pediatr 2000;159:819–26
   PubMed Web of Science ®Google Scholar
• Clark DA, Nieman GF, Thompson JE, et al. Surfactant displacement by meconium free fatty acids: an alternative explanation for atelectasis in meconium aspiration syndrome. J Pediatr 1987;110:765–70
   PubMed Web of Science ®Google Scholar
• Moses D, Holm BA, Spitale P, et al. Inhibition of pulmonary surfactant function by meconium. Am J Obstet Gynecol 1991;164:477–81
   PubMed Web of Science ®Google Scholar
• Sun B, Curstedt T, Robertson B. Surfactant inhibition in experimental meconium aspiration. Acta Paediatr 1993;82:182–9
   PubMed Web of Science ®Google Scholar
• Sun B, Herting E, Curstedt T, et al. Exogenous surfactant improves lung compliance and oxygenation in adult rats with meconium aspiration. J Appl Physiol 1994;77:1961–71
   PubMed Web of Science ®Google Scholar
• Zagariya A, Bhat R, Navale S, et al. Inhibition of meconium-induced cytokine expression and cell apoptosis by pretreatment with captopril. Pediatrics 2006;117:1722–7
   PubMedGoogle Scholar
• El Shahed AI, Dargaville P, Ohlsson A, et al. Surfactant for meconium aspiration syndrome in full term/near term infants. Cochrane Database Syst Rev 2007;CD002054
   Google Scholar
• Holopainen R, Aho H, Laine J, et al. Human meconium has high phospholipase A2 activity and induces cellular injury and apoptosis in piglet lungs. Pediatr Res 1999;46:626–32
   PubMed Web of Science ®Google Scholar
• Lukkarinen H, Laine J, Lehtonen J, et al. Angiotensin II receptor blockade inhibits pneumocyte apoptosis in experimental meconium aspiration. Pediatr Res 2004;55:326–33
   PubMed Web of Science ®Google Scholar
• Rosenfeld CR, Zagariya AM, Liu XT, et al. Meconium increases type 1 angiotensin II receptor expression and alveolar cell death. Pediatr Res 2008;63:251–6
   PubMed Web of Science ®Google Scholar
• Zagariya A, Sierzputovska M, Navale S, et al. Role of meconium and hypoxia in meconium aspiration-induced lung injury in neonatal rabbits. Mediators Inflamm 2010;2010:204831
   PubMedGoogle Scholar
• Lopez A, Bildfell R. Pulmonary inflammation associated with aspirated meconium and epithelial cells in calves. Vet Pathol 1992;29:104–11
   PubMedGoogle Scholar
• Clark P, Duff P. Inhibition of neutrophil oxidative burst and phagocytosis by meconium. Am J Obstet Gynecol 1995;173:1301–5
   PubMed Web of Science ®Google Scholar
• de Beaufort AJ, Pelikan DM, Elferink JG, et al. Effect of interleukin 8 in meconium on in-vitro neutrophil chemotaxis. Lancet 1998;352:102–5
   PubMed Web of Science ®Google Scholar
• Kytola J, Uotila P, Kaapa P. Meconium stimulates cyclooxygenase-2 expression in rat lungs. Prostaglandins Leukot Essent Fatty Acids 1999;60:107–10
   PubMedGoogle Scholar
• Tamura DY, Moore EE, Partrick DA, et al. Acute hypoxemia in humans enhances the neutrophil inflammatory response. Shock 2002;17:269–73
   PubMed Web of Science ®Google Scholar
• de Beaufort AJ, Bakker AC, van Tol MJ, et al. Meconium is a source of pro-inflammatory substances and can induce cytokine production in cultured A549 epithelial cells. Pediatr Res 2003;54:491–5
   PubMed Web of Science ®Google Scholar
• Kytola J, Kaapa P, Uotila P. Meconium aspiration stimulates cyclooxygenase-2 and nitric oxide synthase-2 expression in rat lungs. Pediatr Res 2003;53:731–6
   PubMedGoogle Scholar
• Lindenskov PH, Castellheim A, Aamodt G, et al. Complement activation reflects severity of meconium aspiration syndrome in newborn pigs. Pediatr Res 2004;56:810–17
   PubMed Web of Science ®Google Scholar
• Castellheim A, Lindenskov PH, Pharo A, et al. Meconium is a potent activator of complement in human serum and in piglets. Pediatr Res 2004;55:310–18
   PubMed Web of Science ®Google Scholar
• Zagariya A, Bhat R, Chari G, et al. Apoptosis of airway epithelial cells in response to meconium. Life Sci 2005;76:1849–58
   PubMed Web of Science ®Google Scholar
• Castellheim A, Lindenskov PH, Pharo A, et al. Meconium aspiration syndrome induces complement-associated systemic inflammatory response in newborn piglets. Scand J Immunol 2005;61:217–25
   PubMed Web of Science ®Google Scholar
• Mollnes TE, Castellheim A, Lindenskov PH, et al. The role of complement in meconium aspiration syndrome. J Perinatol 2008;28:S116–19
   Google Scholar
• Castellheim A, Pharo A, Fung M, et al. Complement C5a is a key mediator of meconium-induced neutrophil activation. Pediatr Res 2005;57:242–7
   PubMedGoogle Scholar
• Okazaki K, Kondo M, Kato M, et al. Serum cytokine and chemokine profiles in neonates with meconium aspiration syndrome. Pediatrics 2008;121:e748–53
   Web of Science ®Google Scholar
• Salvesen B, Fung M, Saugstad OD, et al. Role of complement and CD14 in meconium-induced cytokine formation. Pediatrics 2008;121:e496–505
   Web of Science ®Google Scholar
• Cayabyab RG, Kwong K, Jones C, et al. Lung inflammation and pulmonary function in infants with meconium aspiration syndrome. Pediatr Pulmonol 2007;42:898–905
   PubMedGoogle Scholar
• Salvesen B, Nielsen EW, Harboe M, et al. Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in human cord blood. Mol Immunol 2009;46:688–94
   PubMed Web of Science ®Google Scholar
• Pulkkinen MO, Eskola J, Kleimola V, et al. Pancreatic and catalytic phospholipase A2 in relation to pregnancy, labor and fetal outcome. Gynecol Obstet Invest 1990;29:104–7
   PubMedGoogle Scholar
• Hite RD, Seeds MC, Jacinto RB, et al. Hydrolysis of surfactant-associated phosphatidylcholine by mammalian secretory phospholipases A2. Am J Physiol 1998;275:L740–7
   PubMed Web of Science ®Google Scholar
• Schrama AJ, de Beaufort AJ, Sukul YR, et al. Phospholipase A2 is present in meconium and inhibits the activity of pulmonary surfactant: an in vitro study. Acta Paediatr 2001;90:412–16
   PubMed Web of Science ®Google Scholar
• Kaapa P. Meconium aspiration syndrome: a role for phospholipase A2 in the pathogenesis? Acta Paediatr 2001;90:365–7
   PubMedGoogle Scholar
• Granata F, Petraroli A, Boilard E, et al. Activation of cytokine production by secreted phospholipase A2 in human lung macrophages expressing the M-type receptor. J Immunol 2005;174:464–74
   PubMed Web of Science ®Google Scholar
• Sippola T, Aho H, Peuravuori H, et al. Pancreatic phospholipase A2 contributes to lung injury in experimental meconium aspiration. Pediatr Res 2006;59:641–5
   PubMedGoogle Scholar
• Kaapa P, Soukka H. Phospholipase A2 in meconium-induced lung injury. J Perinatol 2008;28:S120–2
   PubMed Web of Science ®Google Scholar
• De Luca D, Capoluongo E, Rigo V. Secretory phospholipase A2 pathway in various types of lung injury in neonates and infants: a multicentre translational study. BMC Pediatr 2011;11:101
   PubMedGoogle Scholar
• Pruzanski W, Vadas P, Fornasier V. Inflammatory effect of intradermal administration of soluble phospholipase A2 in rabbits. J Invest Dermatol 1986;86:380–3
   PubMedGoogle Scholar
• Niewoehner DE, Rice K, Duane P, et al. Induction of alveolar epithelial injury by phospholipase A2. J Appl Physiol 1989;66:261–7
   PubMed Web of Science ®Google Scholar
• Tocker JE, Durham SK, Welton AF, et al. Phospholipase A2-induced pulmonary and hemodynamic responses in the guinea pig. Effects of enzyme inhibitors and mediators antagonists. Am Rev Respir Dis 1990;142:1193–9
   PubMedGoogle Scholar
• Murakami M, Hara N, Kudo I, et al. Triggering of degranulation in mast cells by exogenous type II phospholipase A2. J Immunol 1993;151:5675–84
   PubMed Web of Science ®Google Scholar
• Kim DK, Fukuda T, Thompson BT, et al. Bronchoalveolar lavage fluid phospholipase A2 activities are increased in human adult respiratory distress syndrome. Am J Physiol 1995;269:L109–18
   PubMed Web of Science ®Google Scholar
• Takasaki J, Kawauchi Y, Yasunaga T, et al. Human type II phospholipase A2-induced Mac-1 expression on human neutrophils. J Leukoc Biol 1996;60:174–80
   PubMedGoogle Scholar
• Triggiani M, Granata F, Oriente A, et al. Secretory phospholipases A2 induce beta-glucuronidase release and IL-6 production from human lung macrophages. J Immunol 2000;164:4908–15
   PubMed Web of Science ®Google Scholar
• Fonteh AN, Marion CR, Barham BJ, et al. Enhancement of mast cell survival: a novel function of some secretory phospholipase A(2) isotypes. J Immunol 2001;167:4161–71
   PubMedGoogle Scholar
• Silliman CC, Moore EE, Zallen G, et al. Presence of the M-type sPLA(2) receptor on neutrophils and its role in elastase release and adhesion. Am J Physiol Cell Physiol 2002;283:C1102–13
   Web of Science ®Google Scholar
• Triggiani M, Granata F, Oriente A, et al. Secretory phospholipases A2 induce cytokine release from blood and synovial fluid monocytes. Eur J Immunol 2002;32:67–76
   PubMedGoogle Scholar
• Fuentes L, Hernandez M, Fernandez-Aviles FJ, et al. Cooperation between secretory phospholipase A2 and TNF-receptor superfamily signaling: implications for the inflammatory response in atherogenesis. Circ Res 2002;91:681–8
   PubMedGoogle Scholar
• Beck G, Yard BA, Schulte J, et al. Secreted phospholipases A2 induce the expression of chemokines in microvascular endothelium. Biochem Biophys Res Commun 2003;300:731–7
   PubMedGoogle Scholar
• Jo EJ, Lee HY, Lee YN, et al. Group IB secretory phospholipase A2 stimulates CXC chemokine ligand 8 production via ERK and NF-kappa B in human neutrophils. J Immunol 2004;173:6433–9
   PubMedGoogle Scholar
• Ramoner R, Putz T, Gander H, et al. Dendritic-cell activation by secretory phospholipase A2. Blood 2005;105:3583–7
   PubMedGoogle Scholar
• Triggiani M, Granata F, Frattini A, et al. Activation of human inflammatory cells by secreted phospholipases A2. Biochim Biophys Acta 2006;1761:1289–300
   PubMed Web of Science ®Google Scholar
• Granata F, Frattini A, Loffredo S, et al. Signaling events involved in cytokine and chemokine production induced by secretory phospholipase A2 in human lung macrophages. Eur J Immunol 2006;36:1938–50
   PubMedGoogle Scholar
• Lambeau G, Gelb MH. Biochemistry and physiology of mammalian secreted phospholipases A2. Annu Rev Biochem 2008;77:495–520
   PubMed Web of Science ®Google Scholar
• Holm BA, Keicher L, Liu MY, et al. Inhibition of pulmonary surfactant function by phospholipases. J Appl Physiol 1991;71:317–21
   PubMed Web of Science ®Google Scholar
• Arbibe L, Koumanov K, Vial D, et al. Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction. J Clin Invest 1998;102:1152–60
   PubMed Web of Science ®Google Scholar
• De Luca D, Minucci A, Zecca E, et al. Bile acids cause secretory phospholipase A2 activity enhancement, revertible by exogenous surfactant administration. Intensive Care Med 2009;35:321–6
   PubMed Web of Science ®Google Scholar
• Romero R, Yoon BH, Chaemsaithong P, et al. Bacteria and endotoxin in meconium-stained amniotic fluid at term: could intra-amniotic infection cause meconium passage? J Matern Fetal Neonatal Med. 2013; Sep 12 [Epub ahead of print]
   Google Scholar
• Stoner CR, Reik LM, Donohue M, et al. Human group II phospholipase A2. Characterization of monoclonal antibodies and immunochemical quantitation of the protein in synovial fluid. J Immunol Methods 1991;145:127–36
   PubMedGoogle Scholar
• Romero R, Brandt F, Sepulveda W, et al. Extracellular phospholipase A2 in term and preterm parturition. Abstract 278. 39th Annual Meeting of the Society for Gynecologic Investigation: March 18--21, 1992: scientific program and abstracts: San Antonio Marriott Rivercenter, San Antonio, Texas
   Google Scholar
• Lisowska-Myjak B, Pachecka J. Trypsin and antitrypsin activities and protein concentration in serial meconium and feces of healthy newborns. J Matern Fetal Neonatal Med 2006;19:477–82
   PubMed Web of Science ®Google Scholar
• Verheij HM, Slotboom AJ, de Haas GH. Structure and function of phospholipase A2. Rev Physiol Biochem Pharmacol 1981;91:91--203
   PubMed Web of Science ®Google Scholar
• Dennis EA. The enzymes. New York: Academic Press; 1983
   Google Scholar
• Vadas P, Pruzanski W. Role of secretory phospholipases A2 in the pathobiology of disease. Lab Invest 1986;55:391–404
   PubMed Web of Science ®Google Scholar
• Waite M. The phospholipases. New York: Plenum Press; 1987
   Google Scholar
• Dennis EA. Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem 1994;269:13057–60
   PubMed Web of Science ®Google Scholar
• Six DA, Dennis EA. The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim Biophys Acta 2000;1488:1–19
   PubMed Web of Science ®Google Scholar
• Valentin E, Lambeau G. Increasing molecular diversity of secreted phospholipases A(2) and their receptors and binding proteins. Biochim Biophys Acta 2000;1488:59–70
   PubMed Web of Science ®Google Scholar
• Kudo I, Murakami M. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat 2002;68–69:3–58
   PubMed Web of Science ®Google Scholar
• Murakami M, Kudo I. Phospholipase A2. J Biochem 2002;131:285–92
   PubMed Web of Science ®Google Scholar
• Schaloske RH, Dennis EA. The phospholipase A2 superfamily and its group numbering system. Biochim Biophys Acta 2006;1761:1246–59
   PubMed Web of Science ®Google Scholar
• Burke JE, Dennis EA. Phospholipase A2 structure/function, mechanism, and signaling. J Lipid Res 2009;50:S237–42
   PubMed Web of Science ®Google Scholar
• Murakami M, Taketomi Y, Girard C, et al. Emerging roles of secreted phospholipase A2 enzymes: lessons from transgenic and knockout mice. Biochimie 2010;92:561–82
   PubMedGoogle Scholar
• Boyanovsky BB, Webb NR. Biology of secretory phospholipase A2. Cardiovasc Drugs Ther 2009;23:61–72
   PubMed Web of Science ®Google Scholar
• Murakami M, Taketomi Y, Sato H, et al. Secreted phospholipase A2 revisited. J Biochem 2011;150:233–55
   Google Scholar
• Burke JE, Dennis EA. Phospholipase A2 biochemistry. Cardiovasc Drugs Ther 2009;23:49–59
   PubMed Web of Science ®Google Scholar
• Murakami M, Taketomi Y, Miki Y, et al. Recent progress in phospholipase A(2) research: from cells to animals to humans. Prog Lipid Res 2011;50:152–92
   PubMed Web of Science ®Google Scholar
• Wiqvist N, Bygdeman M, Green K, et al. Endogenous prostaglandins and the initiation of labor. Acta Obstet Gynecol Scand Suppl 1974;37:7–16
   PubMedGoogle Scholar
• Schwarz BE, Schultz FM, Macdonald PC, et al. Initiation of human parturition. III. Fetal membrane content of prostaglandin E2 and F2alpha precursor. Obstet Gynecol 1975;46:564–8
   PubMedGoogle Scholar
• Csapo AI. Prostaglandins and the initiation of labor. Prostaglandins 1976;12:149–64
   PubMedGoogle Scholar
• Kinoshita K, Satoh K, Sakamoto S. Prostaglandin F2alpha and E1 in plasma and amniotic fluid during human pregnancy and labor. Endocrinol Jpn 1977;24:155–62
   PubMedGoogle Scholar
• Liggins GC, Forster CS, Grieves SA, et al. Control of parturition in man. Biol Reprod 1977;16:39–56
   PubMedGoogle Scholar
• Mitchell MD, Flint AP. Progesterone withdrawal: effects on prostaglandins and parturition. Prostaglandins 1977;14:611–14
   PubMedGoogle Scholar
• Mitchell MD, Bibby JG, Hicks BR, et al. Possible role for prostacyclin in human parturition. Prostaglandins 1978;16:931–7
   PubMed Web of Science ®Google Scholar
• Liggins GC. Initiation of parturition. Br Med Bull 1979;35:145–50
   PubMedGoogle Scholar
• Okita JR, MacDonald PC, Johnston JM. Initiation of human parturition. Am J Obstet Gynecol 1982;142:432–5
   PubMedGoogle Scholar
• Mitchell MD. Mechanisms of human parturition: role of prostaglandins and related compounds. Adv Prostaglandin Thromboxane Leukot Res 1985;15:613–15
   PubMedGoogle Scholar
• Okazaki T, Sagawa N, Ban C, et al. Regulation of prostaglandin formation during human parturition. Adv Prostaglandin Thromboxane Leukot Res 1985;15:617–18
   PubMedGoogle Scholar
• Jenkins DM. Prostaglandins and parturition. Lancet 1985;2:163
   PubMedGoogle Scholar
• Romero R, Mazor M, Wu YK, et al. Bacterial endotoxin and tumor necrosis factor stimulate prostaglandin production by human decidua. Prostaglandins Leukot Essent Fatty Acids 1989;37:183–6
   PubMed Web of Science ®Google Scholar
• Romero R, Wu YK, Mazor M, et al. Amniotic fluid concentration of 5-hydroxyeicosatetraenoic acid is increased in human parturition at term. Prostaglandins Leukot Essent Fatty Acids 1989;35:81–3
   PubMed Web of Science ®Google Scholar
• Romero R, Wu YK, Sirtori M, et al. Amniotic fluid concentrations of prostaglandin F2 alpha, 13,14-dihydro-15-keto-prostaglandin F2 alpha (PGFM) and 11-deoxy-13,14-dihydro-15-keto-11, 16-cyclo-prostaglandin E2 (PGEM-LL) in preterm labor. Prostaglandins 1989;37:149–61
   PubMed Web of Science ®Google Scholar
• Walsh SW. 5-Hydroxyeicosatetraenoic acid, leukotriene C4, and prostaglandin F2 alpha in amniotic fluid before and during term and preterm labor. Am J Obstet Gynecol 1989;161:1352–60
   PubMedGoogle Scholar
• Lundin-Schiller S, Mitchell MD. The role of prostaglandins in human parturition. Prostaglandins Leukot Essent Fatty Acids 1990;39:1–10
   PubMedGoogle Scholar
• Dowling DD, Romero RJ, Mitchell MD, et al. Isolation of multiple substances in amniotic fluid that regulate amnion prostaglandin E2 production: the effects of gestational age and labor. Prostaglandins Leukot Essent Fatty Acids 1991;44:253–5
   PubMed Web of Science ®Google Scholar
• Romero R, Baumann P, Gonzalez R, et al. Amniotic fluid prostanoid concentrations increase early during the course of spontaneous labor at term. Am J Obstet Gynecol 1994;171:1613–20
   PubMed Web of Science ®Google Scholar
• Romero R, Gonzalez R, Baumann P, et al. Topographic differences in amniotic fluid concentrations of prostanoids in women in spontaneous labor at term. Prostaglandins Leukot Essent Fatty Acids 1994;50:97–104
   PubMed Web of Science ®Google Scholar
• Neulen J, Breckwoldt M. Placental progesterone, prostaglandins and mechanisms leading to initiation of parturition in the human. Exp Clin Endocrinol 1994;102:195–202
   PubMedGoogle Scholar
• Mitchell MD, Romero RJ, Edwin SS, et al. Prostaglandins and parturition. Reprod Fertil Dev 1995;7:623–32
   PubMed Web of Science ®Google Scholar
• Romero R, Munoz H, Gomez R, et al. Increase in prostaglandin bioavailability precedes the onset of human parturition. Prostaglandins Leukot Essent Fatty Acids 1996;54:187–91
   PubMed Web of Science ®Google Scholar
• Gomez R, Romero R, Edwin SS, et al. Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intraamniotic infection. Infect Dis Clin North Am 1997;11:135–76
   PubMed Web of Science ®Google Scholar
• Romero R, Gotsch F, Pineles B, et al. Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev 2007;65:S194–202
   PubMed Web of Science ®Google Scholar
• Mitchell MD, Chang MC, Chaiworapongsa T, et al. Identification of 9alpha,11beta-prostaglandin F2 in human amniotic fluid and characterization of its production by human gestational tissues. J Clin Endocrinol Metab 2005;90:4244–8
   PubMed Web of Science ®Google Scholar
• Lee SE, Romero R, Park IS, et al. Amniotic fluid prostaglandin concentrations increase before the onset of spontaneous labor at term. J Matern Fetal Neonatal Med 2008;21:89–94
   PubMed Web of Science ®Google Scholar
• Kamel RM. The onset of human parturition. Arch Gynecol Obstet 2010;281:975–82
   PubMed Web of Science ®Google Scholar
• Menon R, Fortunato SJ, Milne GL, et al. Amniotic fluid eicosanoids in preterm and term births: effects of risk factors for spontaneous preterm labor. Obstet Gynecol 2011;118:121–34
   PubMed Web of Science ®Google Scholar
• Romero R, Emamian M, Wan M, et al. Prostaglandin concentrations in amniotic fluid of women with intra-amniotic infection and preterm labor. Am J Obstet Gynecol 1987;157:1461–7
   PubMed Web of Science ®Google Scholar
• Romero R, Wu YK, Mazor M, et al. Amniotic fluid prostaglandin E2 in preterm labor. Prostaglandins Leukot Essent Fatty Acids 1988;34:141–5
   PubMed Web of Science ®Google Scholar
• Romero R, Wu YK, Mazor M, et al. Amniotic fluid arachidonate lipoxygenase metabolites in preterm labor. Prostaglandins Leukot Essent Fatty Acids 1989;36:69–75
   PubMed Web of Science ®Google Scholar
• Hanna N, Bonifacio L, Weinberger B, et al. Evidence for interleukin-10-mediated inhibition of cyclo- oxygenase-2 expression and prostaglandin production in preterm human placenta. Am J Reprod Immunol 2006;55:19–27
   PubMed Web of Science ®Google Scholar
• Hack CE, Wolbink GJ, Schalkwijk C, et al. A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells. Immunol Today 1997;18:111–15
   PubMedGoogle Scholar
• Uozumi N, Kume K, Nagase T, et al. Role of cytosolic phospholipase A2 in allergic response and parturition. Nature 1997;390:618–22
   PubMed Web of Science ®Google Scholar
• Buckland AG, Wilton DC. The antibacterial properties of secreted phospholipases A(2). Biochim Biophys Acta 2000;1488:71–82
   PubMedGoogle Scholar
• Crowl RM, Stoller TJ, Conroy RR, et al. Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem 1991;266:2647–51
   PubMed Web of Science ®Google Scholar
• Slotboom AJ, van Dam-Mieras MC, Jansen EH, et al. Relationship between structure and activity of pancreatic phospholipase A2. Adv Exp Med Biol 1978;101:137--52
   Google Scholar
• Rosenthal MD, Gordon MN, Buescher ES, et al. Human neutrophils store type II 14-kDa phospholipase A2 in granules and secrete active enzyme in response to soluble stimuli. Biochem Biophys Res Commun 1995;208:650–6
   PubMed Web of Science ®Google Scholar
• Blom M, Tool AT, Wever PC, et al. Human eosinophils express, relative to other circulating leukocytes, large amounts of secretory 14-kD phospholipase A2. Blood 1998;91:3037–43
   PubMedGoogle Scholar
• Triggiani M, Granata F, Balestrieri B, et al. Secretory phospholipases A2 activate selective functions in human eosinophils. J Immunol 2003;170:3279–88
   PubMed Web of Science ®Google Scholar
• Asaoka Y, Yoshida K, Sasaki Y, et al. Possible role of mammalian secretory group II phospholipase A2 in T-lymphocyte activation: implication in propagation of inflammatory reaction. Proc Natl Acad Sci U S A 1993;90:716–19
   PubMedGoogle Scholar
• Ho IC, Arm JP, Bingham 3rd CO, et al. A novel group of phospholipase A2s preferentially expressed in type 2 helper T cells. J Biol Chem 2001;276:18321–6
   PubMedGoogle Scholar
• Inada M, Tojo H, Kawata S, et al. Preferential distribution of group-II-like phospholipase A2 in mononuclear phagocytic cells in rat spleen and liver. Eur J Biochem 1991;197:323–9
   PubMedGoogle Scholar
• Sipka S, Farkas T, Gergely P, et al. Secretion of phospholipase A2 induced by interactions of human platelets with monocytes. Ann Hematol 1994;69:307–10
   PubMedGoogle Scholar
• Hidi R, Vargaftig BB, Touqui L. Increased synthesis and secretion of a 14-kDa phospholipase A2 by guinea pig alveolar macrophages. Dissociation from arachidonic acid liberation and modulation by dexamethasone. J Immunol 1993;151:5613–23
   PubMed Web of Science ®Google Scholar
• Fonteh AN, Bass DA, Marshall LA, et al. Evidence that secretory phospholipase A2 plays a role in arachidonic acid release and eicosanoid biosynthesis by mast cells. J Immunol 1994;152:5438–46
   PubMed Web of Science ®Google Scholar
• Kramer RM, Hession C, Johansen B, et al. Structure and properties of a human non-pancreatic phospholipase A2. J Biol Chem 1989;264:5768–75
   PubMed Web of Science ®Google Scholar
• Hara S, Kudo I, Chang HW, et al. Purification and characterization of extracellular phospholipase A2 from human synovial fluid in rheumatoid arthritis. J Biochem 1989;105:395–9
   PubMed Web of Science ®Google Scholar
• Seilhamer JJ, Pruzanski W, Vadas P, et al. Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. J Biol Chem 1989;264:5335–8
   PubMed Web of Science ®Google Scholar
• Fierlbeck G, Rassner G, Muller C. Psoriasis induced at the injection site of recombinant interferon gamma. Results of immunohistologic investigations. Arch Dermatol 1990;126:351–5
   PubMed Web of Science ®Google Scholar
• Kortekangas P, Aro HT, Nevalainen TJ. Group II phospholipase A2 in synovial fluid and serum in acute arthritis. Scand J Rheumatol 1994;23:68–72
   PubMed Web of Science ®Google Scholar
• Bidgood MJ, Jamal OS, Cunningham AM, et al. Type IIA secretory phospholipase A2 up-regulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes. J Immunol 2000;165:2790–7
   PubMed Web of Science ®Google Scholar
• Vadas P. Elevated plasma phospholipase A2 levels: correlation with the hemodynamic and pulmonary changes in gram-negative septic shock. J Lab Clin Med 1984;104:873–81
   PubMed Web of Science ®Google Scholar
• Haapamaki MM, Gronroos JM, Nurmi H, et al. Elevated group II phospholipase A2 mass concentration in serum and colonic mucosa in Crohn's disease. Clin Chem Lab Med 1998;36:751–5
   PubMed Web of Science ®Google Scholar
• Haapamaki MM, Gronroos JM, Nurmi H, et al. Phospholipase A2 in serum and colonic mucosa in ulcerative colitis. Scand J Clin Lab Invest 1999;59:279–87
   PubMedGoogle Scholar
• Nevalainen TJ, Gronroos JM, Kortesuo PT. Pancreatic and synovial type phospholipases A2 in serum samples from patients with severe acute pancreatitis. Gut 1993;34:1133–6
   PubMed Web of Science ®Google Scholar
• Kemppainen E, Hietaranta A, Puolakkainen P, et al. Bactericidal/permeability-increasing protein and group I and II phospholipase A2 during the induction phase of human acute pancreatitis. Pancreas 1999;18:21–7
   PubMedGoogle Scholar
• Miura M, Endo S, Kaku LL, et al. Plasma type II phospholipase A2 levels in patients with acute pancreatitis. Res Commun Mol Pathol Pharmacol 2001;109:159–64
   PubMedGoogle Scholar
• Lin MK, Farewell V, Vadas P, et al. Secretory phospholipase A2 as an index of disease activity in rheumatoid arthritis. Prospective double blind study of 212 patients. J Rheumatol 1996;23:1162–6
   PubMedGoogle Scholar
• Elsbach P, Weiss J, Franson RC, et al. Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. Observations on their relationship. J Biol Chem 1979;254:11000–9
   PubMed Web of Science ®Google Scholar
• Harwig SS, Tan L, Qu XD, et al. Bactericidal properties of murine intestinal phospholipase A2. J Clin Invest 1995;95:603–10
   PubMed Web of Science ®Google Scholar
• Weinrauch Y, Abad C, Liang NS, et al. Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group IIA phospholipase A2. J Clin Invest 1998;102:633–8
   PubMedGoogle Scholar
• Laine VJ, Grass DS, Nevalainen TJ. Resistance of transgenic mice expressing human group II phospholipase A2 to Escherichia coli infection. Infect Immun 2000;68:87–92
   PubMedGoogle Scholar
• Beers SA, Buckland AG, Koduri RS, et al. The antibacterial properties of secreted phospholipases A2: a major physiological role for the group IIA enzyme that depends on the very high pI of the enzyme to allow penetration of the bacterial cell wall. J Biol Chem 2002;277:1788–93
   PubMedGoogle Scholar
• Koprivnjak T, Peschel A, Gelb MH, et al. Role of charge properties of bacterial envelope in bactericidal action of human group IIA phospholipase A2 against Staphylococcus aureus. J Biol Chem 2002;277:47636–44
   PubMedGoogle Scholar
• Koduri RS, Gronroos JO, Laine VJ, et al. Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A(2). J Biol Chem 2002;277:5849–57
   PubMed Web of Science ®Google Scholar
• Gimenez AP, Wu YZ, Paya M, et al. High bactericidal efficiency of type iia phospholipase A2 against Bacillus anthracis and inhibition of its secretion by the lethal toxin. J Immunol 2004;173:521–30
   PubMed Web of Science ®Google Scholar
• Piris-Gimenez A, Paya M, Lambeau G, et al. In vivo protective role of human group IIa phospholipase A2 against experimental anthrax. J Immunol 2005;175:6786–91
   PubMed Web of Science ®Google Scholar
• Femling JK, Nauseef WM, Weiss JP. Synergy between extracellular group IIA phospholipase A2 and phagocyte NADPH oxidase in digestion of phospholipids of Staphylococcus aureus ingested by human neutrophils. J Immunol 2005;175:4653–61
   PubMed Web of Science ®Google Scholar
• Huhtinen HT, Gronroos JO, Gronroos JM, et al. Antibacterial effects of human group IIA and group XIIA phospholipase A2 against Helicobacter pylori in vitro. APMIS 2006;114:127–30
   PubMedGoogle Scholar
• Sitkiewicz I, Stockbauer KE, Musser JM. Secreted bacterial phospholipase A2 enzymes: better living through phospholipolysis. Trends Microbiol 2007;15:63–9
   PubMedGoogle Scholar
• Weinrauch Y, Elsbach P, Madsen LM, et al. The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. J Clin Invest 1996;97:250–7
   PubMedGoogle Scholar
• Gronroos JO, Laine VJ, Nevalainen TJ. Bactericidal group IIA phospholipase A2 in serum of patients with bacterial infections. J Infect Dis 2002;185:1767–72
   PubMedGoogle Scholar
• Fenard D, Lambeau G, Maurin T, et al. A peptide derived from bee venom-secreted phospholipase A2 inhibits replication of T-cell tropic HIV-1 strains via interaction with the CXCR4 chemokine receptor. Mol Pharmacol 2001;60:341–7
   PubMedGoogle Scholar
• Mitsuishi M, Masuda S, Kudo I, et al. Group V and X secretory phospholipase A2 prevents adenoviral infection in mammalian cells. Biochem J 2006;393:97–106
   PubMedGoogle Scholar
• Kim JO, Chakrabarti BK, Guha-Niyogi A, et al. Lysis of human immunodeficiency virus type 1 by a specific secreted human phospholipase A2. J Virol 2007;81:1444–50
   PubMedGoogle Scholar
• Deregnaucourt C, Schrevel J. Bee venom phospholipase A2 induces stage-specific growth arrest of the intraerythrocytic Plasmodium falciparum via modifications of human serum components. J Biol Chem 2000;275:39973–80
   PubMedGoogle Scholar
• Aho HJ, Saari KM, Kallajoki M, et al. Synthesis of group II phospholipase A2 and lysozyme in lacrimal glands. Invest Ophthalmol Vis Sci 1996;37:1826–32
   PubMedGoogle Scholar
• Saari KM, Aho V, Paavilainen V, et al. Group II PLA(2) content of tears in normal subjects. Invest Ophthalmol Vis Sci 2001;42:318–20
   PubMed Web of Science ®Google Scholar
• Nevalainen TJ, Meri KM, Niemi M. Synovial-type (group II) phospholipase A2 human seminal plasma. Andrologia 1993;25:355–8
   PubMed Web of Science ®Google Scholar
• Nevalainen TJ, Haapanen TJ. Distribution of pancreatic (group I) and synovial-type (group II) phospholipases A2 in human tissues. Inflammation 1993;17:453–64
   PubMed Web of Science ®Google Scholar
• Qu XD, Lloyd KC, Walsh JH, et al. Secretion of type II phospholipase A2 and cryptdin by rat small intestinal Paneth cells. Infect Immun 1996;64:5161–5
   PubMedGoogle Scholar
• Nevalainen TJ, Eerola LI, Rintala E, et al. Time-resolved fluoroimmunoassays of the complete set of secreted phospholipases A2 in human serum. Biochim Biophys Acta 2005;1733:210–23
   PubMedGoogle Scholar
• Henderson Jr WR, Chi EY, Bollinger JG, et al. Importance of group X-secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model. J Exp Med 2007;204:865–77
   PubMed Web of Science ®Google Scholar
• Schwarz BE, Schultz FM, MacDonald PC, et al. Initiation of human parturition. IV. Demonstration of phospholipase A2 in the lysosomes of human fetal membranes. Am J Obstet Gynecol 1976;125:1089–92
   PubMedGoogle Scholar
• Gustavii B. The distribution within the placenta, myometrium, and decidua of 24Na-labelled hypertonic solution following intra-amniotic or extra-amniotic injection. Br J Obstet Gynaecol. 1975;82:734--9
   Google Scholar
• Akesson B, Gustavii B. Occurrence of phospholipase A1 and A2 in human decidua. Prostaglandins 1975;9:667--73
   Google Scholar
• Gebhardt DD, Beintema A, Reman FC, et al. Phospholipase-A2 in amniotic fluid. Lancet 1978;2:1159
   PubMedGoogle Scholar
• Gebhardt DO, Beintema A, Reman FC, et al. The lipoprotein composition of amniotic fluid. Clin Chim Acta 1979;94:93–100
   PubMed Web of Science ®Google Scholar
• Farrugia W, Aitken MA, van Dunne F, et al. Type II phospholipase A2 in human gestational tissues: subcellular distribution of placental immuno- and catalytic activity. Biochim Biophys Acta 1993;1166:77–83
   PubMedGoogle Scholar
• Aitken MA, Farrugia W, Wong MH, et al. Type II phospholipase A2 in human gestational tissues: extractable immuno- and enzymatic activity in fetal membranes. Biochim Biophys Acta 1993;1170:314–20
   PubMedGoogle Scholar
• Farrugia W, Rice GE, Wong MH, et al. Release of Type II phospholipase A2 immunoreactivity and phospholipase A2 enzymatic activity from human placenta. J Endocrinol 1997;153:151–7
   PubMedGoogle Scholar
• Koyama M, Ito S, Nakajima A, et al. Elevations of group II phospholipase A2 concentrations in serum and amniotic fluid in association with preterm labor. Am J Obstet Gynecol 2000;183:1537–43
   PubMedGoogle Scholar